Exercise experiences in patients with metastatic lung cancer: A qualitative approach.
Aged
Antineoplastic Agents
/ therapeutic use
Exercise
/ psychology
Exercise Therapy
/ methods
Female
Hospitalization
Humans
Lung Neoplasms
/ drug therapy
Lymphatic Metastasis
Male
Middle Aged
Motivation
/ physiology
Qualitative Research
Sedentary Behavior
Surveys and Questionnaires
Taiwan
Walking
/ physiology
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
07
2019
accepted:
24
02
2020
entrez:
3
4
2020
pubmed:
3
4
2020
medline:
2
7
2020
Statut:
epublish
Résumé
Patients with metastatic lung cancer can have severe cancer-related symptoms and treatment-induced side effects. Exercise is beneficial for patients with metastatic lung cancer; however, little information is available on guiding patients how to perform exercise during hospitalization. The purpose of this qualitative study was to understand exercise experiences in patients with metastatic lung cancer. Patients with metastatic lung cancer (n = 24) participated in face-to-face in-depth interviews at an inpatient ward of a medical center in central Taiwan. Interview transcripts were evaluated using narrative analysis to extract and validate themes. Three primary themes were identified: (1) modifying exercise to maximize physical functions; (2) living with symptoms and frustration, but still exercising; and (3) doing exercise to sustain hopes, inner power, and life. Secondary findings included: (1) adopting walking as their main form of exercise because of its convenience; and (2) among patients with severe symptoms, adjusting exercise towards shorter time durations and shorter distances, slower speeds, and higher frequencies. The study found physically active lung cancer patients, although with metastatic condition, adjusted their exercise activities to balance disease and treatment-induced deteriorations and boost themselves to feel hope and fight for cancer. However, the results may not be applicable to physically inactive patients. Future research to explore experiences from those with even worse physical conditions and further helping them to take some mild exercise to enhance the positive side of cancer experiences are suggested.
Sections du résumé
BACKGROUND
Patients with metastatic lung cancer can have severe cancer-related symptoms and treatment-induced side effects. Exercise is beneficial for patients with metastatic lung cancer; however, little information is available on guiding patients how to perform exercise during hospitalization. The purpose of this qualitative study was to understand exercise experiences in patients with metastatic lung cancer.
METHODS
Patients with metastatic lung cancer (n = 24) participated in face-to-face in-depth interviews at an inpatient ward of a medical center in central Taiwan. Interview transcripts were evaluated using narrative analysis to extract and validate themes.
RESULTS
Three primary themes were identified: (1) modifying exercise to maximize physical functions; (2) living with symptoms and frustration, but still exercising; and (3) doing exercise to sustain hopes, inner power, and life. Secondary findings included: (1) adopting walking as their main form of exercise because of its convenience; and (2) among patients with severe symptoms, adjusting exercise towards shorter time durations and shorter distances, slower speeds, and higher frequencies.
CONCLUSIONS
The study found physically active lung cancer patients, although with metastatic condition, adjusted their exercise activities to balance disease and treatment-induced deteriorations and boost themselves to feel hope and fight for cancer. However, the results may not be applicable to physically inactive patients. Future research to explore experiences from those with even worse physical conditions and further helping them to take some mild exercise to enhance the positive side of cancer experiences are suggested.
Identifiants
pubmed: 32240205
doi: 10.1371/journal.pone.0230188
pii: PONE-D-19-19518
pmc: PMC7117721
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0230188Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur J Cancer. 2008 May;44(8):1169-74
pubmed: 18359220
Psychooncology. 2018 Feb;27(2):563-568
pubmed: 28763133
Integr Cancer Ther. 2015 Jul;14(4):341-9
pubmed: 25800229
Thorax. 2019 Aug;74(8):787-796
pubmed: 31048509
PM R. 2018 Aug;10(8):843-864
pubmed: 29474996
J Pain Symptom Manage. 2008 Apr;35(4):347-55
pubmed: 18243642
J Thorac Oncol. 2015 Jun;10(6):861-71
pubmed: 25831230
Support Care Cancer. 2020 Jan;28(1):99-112
pubmed: 30982092
Lung Cancer. 2012 May;76(2):248-52
pubmed: 22112290
Support Care Cancer. 2017 Mar;25(3):983-999
pubmed: 27900549
J Pain Symptom Manage. 2013 May;45(5):811-21
pubmed: 23017624
Eur J Oncol Nurs. 2019 Aug;41:16-23
pubmed: 31358249
J Clin Med. 2019 Aug 23;8(9):
pubmed: 31450784
Public Health Nutr. 2004 Sep;7(6):773-81
pubmed: 15369616
Brain Behav Immun. 2013 Mar;30 Suppl:S75-87
pubmed: 22610066
Soc Sci Med. 2007 Jan;64(1):138-49
pubmed: 17011094
Cochrane Database Syst Rev. 2018 Sep 19;9:CD010192
pubmed: 30229557
Lung Cancer. 2012 Feb;75(2):203-8
pubmed: 21816503
J Thorac Oncol. 2013 Dec;8(12):1545-50
pubmed: 24389436
J Thorac Oncol. 2009 May;4(5):595-601
pubmed: 19276834
BMC Cancer. 2018 Feb 13;18(1):178
pubmed: 29433474
J Sci Med Sport. 2019 Nov;22(11):1175-1199
pubmed: 31277921
Support Care Cancer. 2018 Mar;26(3):685-700
pubmed: 29185105
Eur J Cancer. 1996 Jun;32A(7):1135-41
pubmed: 8758243
Int J Nurs Stud. 2015 Jan;52(1):207-15
pubmed: 25457877
Crit Rev Oncol Hematol. 2003 Nov;48(2):179-84
pubmed: 14607381
Thorax. 2013 Jun;68(6):551-64
pubmed: 23399908
Sports Med. 2009;39(5):389-422
pubmed: 19402743
Acta Oncol. 2015 May;54(5):609-17
pubmed: 25751760
Health Educ Res. 1997 Sep;12(3):363-74
pubmed: 10174219
Eur J Cancer Care (Engl). 2019 Jan;28(1):e12946
pubmed: 30284343
J Natl Cancer Inst. 2012 Jun 6;104(11):797-9
pubmed: 22570316
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Clin J Oncol Nurs. 2012 Jun 1;16(3):293-300
pubmed: 22641322
CA Cancer J Clin. 2013 Sep;63(5):295-317
pubmed: 23856764
CMAJ. 2014 Oct 7;186(14):1071-5
pubmed: 25047989
Support Care Cancer. 2014 Jan;22(1):95-101
pubmed: 23995813
Oncol Nurs Forum. 2014 Mar 1;41(2):E44-55
pubmed: 24578085
Cancer Invest. 2004;22(1):68-81
pubmed: 15069764
Ann Oncol. 2017 Aug 1;28(8):1889-1897
pubmed: 28459989
Support Care Cancer. 2015 May;23(5):1383-9
pubmed: 25358644
Integr Cancer Ther. 2018 Sep;17(3):921-927
pubmed: 29900753
Support Care Cancer. 2012 Dec;20(12):3169-77
pubmed: 22526147
Br J Sports Med. 2009 Jun;43(6):392-400
pubmed: 19224911
Lung Cancer. 2013 Aug;81(2):288-93
pubmed: 23561304
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818
Pain Ther. 2017 Jun;6(1):85-91
pubmed: 28260158
Health Educ Res. 2005 Apr;20(2):226-36
pubmed: 15479707
Clin Lung Cancer. 2017 May;18(3):274-280.e6
pubmed: 28185791
Support Care Cancer. 2016 Jan;24(1):129-137
pubmed: 25957013
J Pain Symptom Manage. 2012 Jul;44(1):84-94
pubmed: 22770487
BMC Cancer. 2013 Oct 14;13:477
pubmed: 24124893
J Aging Stud. 2016 Jan;36:17-25
pubmed: 26880601
Scand J Med Sci Sports. 2012 Dec;22(6):804-15
pubmed: 21599754
J Obes. 2012;2012:546459
pubmed: 22778918
Lung Cancer. 2011 May;72(2):139-53
pubmed: 21316790
J Pain Symptom Manage. 2002 May;23(5):417-23
pubmed: 12007759
J Thorac Oncol. 2016 Oct;11(10):1653-71
pubmed: 27364315
Nat Rev Clin Oncol. 2012 Mar 06;9(5):288-96
pubmed: 22392097